Ra Medical Systems, Inc. (NYSE:RMED) headquartered in Carlsbad, will host a conference call for the investment community to discuss the 3Q20 earnings result on 12th November 2020 at 4:30 PM Eastern Time.
Those interested in listening to the conference call live via the Internet can visit www.ramed.com
Individuals interested in participating in the audio call may dial the listen only number(s) 866-777-2509 U.S. or 412-317-5413 Toll Number, with passcode : 10149446
Earnings Expectation
Ra Medical Systems, Inc. is set to announce third quarter earning results on Thursday 12th November 2020, after market close.
Analysts surveyed by Thomson Reuters are predicting, RMED to report 3Q20 loss of $ 0.13 per share. For the full year, analysts anticipate top line of $ 4.76 million, while looking forward to loss of $ 1 per share bottom line.
Ra Medical Systems, Inc., a commercial-stage medical device company, develops, manufactures, and markets excimer lasers for use in the treatment of vascular and dermatological diseases. The company offers DABRA (destruction of arteriosclerotic blockages by laser radiation ablation), a minimally-invasive excimer laser and disposable catheter system that is used by physicians in the endovascular treatment of vascular blockages resulting from lower extremity vascular disease. It also provides Pharos, an excimer laser device that emits highly concentrated ultraviolet light used in the treatment of dermatological skin disorders.
